Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 4 | 2022 | 559 | 1.890 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2022 | 54 | 1.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 1176 | 1.190 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 738 | 1.010 |
Why?
|
| Blood Glucose | 5 | 2022 | 836 | 1.010 |
Why?
|
| Propensity Score | 1 | 2024 | 147 | 0.900 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 257 | 0.720 |
Why?
|
| Appointments and Schedules | 2 | 2023 | 54 | 0.700 |
Why?
|
| Telemedicine | 2 | 2020 | 185 | 0.690 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 56 | 0.670 |
Why?
|
| Insulin Infusion Systems | 1 | 2018 | 36 | 0.630 |
Why?
|
| Cost-Benefit Analysis | 5 | 2022 | 461 | 0.610 |
Why?
|
| Inpatients | 1 | 2020 | 310 | 0.560 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 359 | 0.550 |
Why?
|
| Insulin | 2 | 2018 | 1146 | 0.550 |
Why?
|
| Hypertension | 1 | 2022 | 741 | 0.550 |
Why?
|
| Medicaid | 3 | 2024 | 229 | 0.530 |
Why?
|
| Adult | 14 | 2024 | 26508 | 0.430 |
Why?
|
| Quality of Life | 4 | 2023 | 1662 | 0.420 |
Why?
|
| Population Health | 2 | 2023 | 33 | 0.420 |
Why?
|
| Primary Health Care | 5 | 2024 | 351 | 0.400 |
Why?
|
| Asthma | 1 | 2020 | 976 | 0.390 |
Why?
|
| Hypothyroidism | 2 | 2023 | 238 | 0.380 |
Why?
|
| United States | 8 | 2024 | 6957 | 0.370 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2022 | 142 | 0.360 |
Why?
|
| Humans | 30 | 2024 | 89073 | 0.350 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 111 | 0.340 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 435 | 0.330 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 1706 | 0.320 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2023 | 257 | 0.320 |
Why?
|
| Depression | 5 | 2023 | 503 | 0.300 |
Why?
|
| Community Health Centers | 3 | 2023 | 115 | 0.300 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 2 | 2022 | 35 | 0.250 |
Why?
|
| Triiodothyronine | 2 | 2023 | 344 | 0.240 |
Why?
|
| Thyroxine | 2 | 2023 | 350 | 0.240 |
Why?
|
| Insurance Claim Review | 1 | 2024 | 45 | 0.230 |
Why?
|
| Texas | 1 | 2024 | 113 | 0.230 |
Why?
|
| Thyroid Hormones | 2 | 2023 | 328 | 0.220 |
Why?
|
| Male | 9 | 2024 | 42254 | 0.220 |
Why?
|
| Aged | 8 | 2023 | 19078 | 0.220 |
Why?
|
| Physicians | 2 | 2023 | 689 | 0.220 |
Why?
|
| Patient Care Bundles | 1 | 2023 | 20 | 0.220 |
Why?
|
| Patient Portals | 1 | 2023 | 17 | 0.220 |
Why?
|
| Middle Aged | 6 | 2024 | 25865 | 0.210 |
Why?
|
| Hypoglycemic Agents | 3 | 2022 | 348 | 0.210 |
Why?
|
| Female | 9 | 2024 | 46014 | 0.210 |
Why?
|
| Hyperthyroidism | 1 | 2022 | 75 | 0.200 |
Why?
|
| Office Visits | 1 | 2022 | 50 | 0.200 |
Why?
|
| Hormone Replacement Therapy | 1 | 2022 | 82 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2023 | 235 | 0.200 |
Why?
|
| Patient Outcome Assessment | 1 | 2022 | 84 | 0.190 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2022 | 105 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 95 | 0.190 |
Why?
|
| Metformin | 1 | 2022 | 124 | 0.190 |
Why?
|
| Psychiatry | 1 | 2022 | 82 | 0.190 |
Why?
|
| Financing, Organized | 1 | 2020 | 12 | 0.180 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2020 | 24 | 0.180 |
Why?
|
| Chronic Pain | 1 | 2022 | 162 | 0.170 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 424 | 0.170 |
Why?
|
| Computer Simulation | 1 | 2024 | 1097 | 0.170 |
Why?
|
| Colorado | 1 | 2019 | 37 | 0.170 |
Why?
|
| Adolescent | 3 | 2022 | 9237 | 0.170 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 53 | 0.170 |
Why?
|
| Intention to Treat Analysis | 1 | 2019 | 69 | 0.170 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 185 | 0.170 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 105 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2018 | 20 | 0.150 |
Why?
|
| Monitoring, Ambulatory | 1 | 2018 | 32 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2018 | 76 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2020 | 779 | 0.150 |
Why?
|
| Hypoglycemia | 1 | 2018 | 107 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2023 | 4273 | 0.140 |
Why?
|
| Hospitals | 3 | 2023 | 299 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 414 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2752 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 461 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2018 | 341 | 0.120 |
Why?
|
| Hospitalization | 3 | 2024 | 876 | 0.110 |
Why?
|
| Nutrition Surveys | 2 | 2023 | 109 | 0.100 |
Why?
|
| Thyrotropin | 2 | 2023 | 286 | 0.100 |
Why?
|
| Sodium | 2 | 2022 | 331 | 0.090 |
Why?
|
| Young Adult | 2 | 2019 | 6289 | 0.090 |
Why?
|
| Glucose | 2 | 2022 | 630 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2022 | 865 | 0.070 |
Why?
|
| Attitude of Health Personnel | 2 | 2022 | 643 | 0.060 |
Why?
|
| Self-Management | 1 | 2024 | 39 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 21 | 0.060 |
Why?
|
| Maryland | 1 | 2023 | 42 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 181 | 0.050 |
Why?
|
| Thyroid Function Tests | 1 | 2023 | 120 | 0.050 |
Why?
|
| Housing | 1 | 2023 | 45 | 0.050 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 45 | 0.050 |
Why?
|
| Telephone | 1 | 2022 | 35 | 0.050 |
Why?
|
| Rural Population | 1 | 2023 | 143 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 375 | 0.050 |
Why?
|
| Poverty | 1 | 2023 | 180 | 0.050 |
Why?
|
| Social Support | 1 | 2023 | 208 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 192 | 0.050 |
Why?
|
| Opiate Substitution Treatment | 1 | 2020 | 40 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 423 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 948 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 521 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2023 | 447 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 349 | 0.040 |
Why?
|
| Length of Stay | 1 | 2022 | 732 | 0.040 |
Why?
|
| Patient Selection | 1 | 2022 | 682 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 442 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2022 | 599 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2023 | 2863 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2291 | 0.030 |
Why?
|
| Child | 1 | 2024 | 7149 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2612 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 8203 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 9003 | 0.020 |
Why?
|